LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Acetylcysteine Solution, USP, 10% in multiple presentations – 4 mL, 10 mL and 30 mL vials – with immediate availability. Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition.
Until recently, Acetylcysteine Solution, USP vial for inhalation (mucolytic agent) or oral administration (acetaminophen antidote) has been on the drug-shortage lists maintained by both the U.S. Food and Drug Administration and the American Society of Health-System Pharmacists.
Help employers find you! Check out all the jobs and post your resume.
